Literature for peptidase C01.063: falcipain-3
(References are filtered for relevance to Inhibitor. To remove the filter click here. See explanation.)
-
Madhav,H., Reddy,G.S., Rizvi,Z., Jameel,E., Patel,T.S., Rahman,A., Yadav,V., Fatima,S., Heyat,F., Pal,K., Minju-Op,A., Subbarao,N., Bhattacharjee,S., Dixit,B.C., Sijwali,P.S. and Hoda,N.
Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of Plasmodial cysteine protease inhibitors for the treatment of malaria
RSC Med Chem (2024) 15, 1022-1037. PubMed Europe PubMed DOI PMC EPMC I -
Rana,D., Kalamuddin,M., Sundriyal,S., Jaiswal,V., Sharma,G., Das Sarma,K., Sijwali,P.S., Mohmmed,A., Malhotra,P. and Mahindroo,N.
Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity
Bioorg Med Chem (2019) , 115155-115155. PubMed Europe PubMed DOI I -
Stoye,A., Juillard,A., Tang,A.H., Legac,J., Gut,J., White,K.L., Charman,S.A., Rosenthal,P.J., Grau,G.E.R., Hunt,N.H. and Payne,R.J.
Falcipain inhibitors based on the natural product gallinamide A are potent in vitro and in vivo antimalarials
J Med Chem (2019) 62, 5562-5578. PubMed Europe PubMed DOI I -
Bekono,B.D., Ntie-Kang,F., Owono Owono,L.C. and Megnassan,E.
Targeting cysteine proteases from Plasmodium falciparum: a general overview, rational drug design and computational approaches for drug discovery
Curr Drug Targets (2018) 19, 501-526. PubMed Europe PubMed DOI I -
Saddala,M.S. and Adi,P.J.
Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax vivapain-3 (VP-3)
Heliyon (2018) 4, e00612-e00612. PubMed Europe PubMed DOI PMC EPMC I -
Musyoka,T.M., Kanzi,A.M., Lobb,K.A. and Tastan Bishop,O.
Structure based docking and molecular dynamic studies of plasmodial cysteine proteases against a South African natural compound and its analogs
Sci Rep (2016) 6, 23690-23690. PubMed Europe PubMed DOI PMC EPMC I -
Musyoka,T.M., Kanzi,A.M., Lobb,K.A. and Tastan Bishop,O.
Analysis of non-peptidic compounds as potential malarial inhibitors against plasmodial cysteine proteases via integrated virtual screening workflow
J Biomol Struct Dyn (2016) 34, 2084-2101. PubMed Europe PubMed DOI I -
Poongavanam,V. and Kongsted,J.
Binding affinity models for falcipain inhibition based on the linear interaction energy method
J Mol Graph Model (2016) 70, 236-245. PubMed Europe PubMed DOI I -
Conroy,T., Guo,J.T., Elias,N., Cergol,K.M., Gut,J., Legac,J., Khatoon,L., Liu,Y., McGowan,S., Rosenthal,P.J., Hunt,N.H. and Payne,R.J.
Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials
J Med Chem (2014) 57, 10557-10563. PubMed Europe PubMed DOI I -
Weldon,D.J., Shah,F., Chittiboyina,A.G., Sheri,A., Chada,R.R., Gut,J., Rosenthal,P.J., Shivakumar,D., Sherman,W., Desai,P., Jung,J.C. and Avery,M.A.
Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of alpha-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum
Bioorg Med Chem Lett (2014) 24, 1274-1279. PubMed Europe PubMed DOI I -
Kesharwani,R.K., Singh,D.V. and Misra,K.
Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: A structure-based drug designing approach
J Vector Borne Dis (2013) 50, 93-102. PubMed Europe PubMed I -
Mane,U.R., Gupta,R.C., Nadkarni,S.S., Giridhar,R.R., Naik,P.P. and Yadav,M.R.
Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review
Expert Opin Ther Pat (2013) 23, 165-187. PubMed Europe PubMed DOI V I -
Rathi,B., Singh,A.K., Kishan,R., Singh,N., Latha,N., Srinivasan,S., Pandey,K.C., Tiwari,H.K. and Singh,B.K.
Functionalized hydroxyethylamine based peptide nanostructures as potential inhibitors of falcipain-3, an essential proteases of Plasmodium falciparum
Bioorg Med Chem (2013) 21, 5503-5509. PubMed Europe PubMed DOI I -
Wang,J., Li,F., Li,Y., Yang,Y., Zhang,S. and Yang,L.
Structural features of falcipain-3 inhibitors: an in silico study
Mol Biosyst (2013) 9, 2296-2310. PubMed Europe PubMed DOI I -
Chintakrindi,A.S., Shaikh,M.S. and Coutinho,E.C.
De novo design of 7-aminocoumarin derivatives as novel falcipain-3 inhibitors
J Mol Model (2012) 18, 1481-1493. PubMed Europe PubMed DOI I -
Marco,M. and Coteron,J.M.
Falcipain inhibition as a promising antimalarial target
Curr Top Med Chem (2012) 12, 408-444. PubMed Europe PubMed DOI I -
Pandey,K.C. and Dixit,R.
Structure-function of falcipains: malarial cysteine proteases
J Trop Med (2012) 2012, 345195-345195. PubMed Europe PubMed DOI I -
Shah,F., Gut,J., Legac,J., Shivakumar,D., Sherman,W., Rosenthal,P.J. and Avery,M.A.
Computer-aided drug design of falcipain inhibitors: virtual screening, structure-activity relationships, hydration site thermodynamics, and reactivity analysis
J Chem Inf Model (2012) 52, 696-710. PubMed Europe PubMed DOI I -
Potshangbam,A.M., Tanneeru,K., Reddy,B.M. and Guruprasad,L.
3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3
Bioorg Med Chem Lett (2011) 21, 7219-7223. PubMed Europe PubMed DOI I -
Shah,F., Mukherjee,P., Gut,J., Legac,J., Rosenthal,P.J., Tekwani,B.L. and Avery,M.A.
Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library
J Chem Inf Model (2011) 51, 852-864. PubMed Europe PubMed DOI I -
Breuning,A., Degel,B., Schulz,F., Buchold,C., Stempka,M., Machon,U., Heppner,S., Gelhaus,C., Leippe,M., Leyh,M., Kisker,C., Rath,J., Stich,A., Gut,J., Rosenthal,P.J., Schmuck,C. and Schirmeister,T.
Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids
J Med Chem (2010) 53, 1951-1963. PubMed Europe PubMed DOI I -
Coteron,J.M., Catterick,D., Castro,J., Chaparro,M.J., Diaz,B., Fernandez,E., Ferrer,S., Gamo,F.J., Gordo,M., Gut,J., de Las Heras,L., Legac,J., Marco,M., Miguel,J., Munoz,V., Porras,E., de la Rosa,J.C., Ruiz,J.R., Sandoval,E., Ventosa,P., Rosenthal,P.J. and Fiandor,J.M.
Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series
J Med Chem (2010) 53, 6129-6152. PubMed Europe PubMed DOI I -
Gibbons,P., Verissimo,E., Araujo,N.C., Barton,V., Nixon,G.L., Amewu,R.K., Chadwick,J., Stocks,P.A., Biagini,G.A., Srivastava,A., Rosenthal,P.J., Gut,J., Guedes,R.C., Moreira,R., Sharma,R., Berry,N., Cristiano,M.L., Shone,A.E., Ward,S.A. and O'Neill,P.M.
Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: toward combination chemotherapy of malaria through a single chemical entity
J Med Chem (2010) 53, 8202-8206. PubMed Europe PubMed DOI I -
Loser,R., Gut,J., Rosenthal,P.J., Frizler,M., Gutschow,M. and Andrews,K.T.
Antimalarial activity of azadipeptide nitriles
Bioorg Med Chem Lett (2010) 20, 252-255. PubMed Europe PubMed DOI I -
Dude,M.A., Kaeppler,U., Herb,M., Schiller,M., Schulz,F., Vedder,B., Heppner,S., Pradel,G., Gut,J., Rosenthal,P.J., Schirmeister,T., Leippe,M. and Gelhaus,C.
Synthesis and evaluation of non-peptidic cysteine protease inhibitors of P. falciparum derived from etacrynic acid
Molecules (2009) 14, 19-35. PubMed Europe PubMed DOI I -
Kerr,I.D., Lee,J.H., Farady,C.J., Marion,R., Rickert,M., Sajid,M., Pandey,K.C., Caffrey,C.R., Legac,J., Hansell,E., McKerrow,J.H., Craik,C.S., Rosenthal,P.J. and Brinen,L.S.
Vinyl sulfones as antiparasitic agents and a structural basis for drug design
J Biol Chem (2009) 284, 25697-25703. PubMed Europe PubMed DOI PMC EPMC S I -
Kerr,I.D., Lee,J.H., Pandey,K.C., Harrison,A., Sajid,M., Rosenthal,P.J. and Brinen,L.S.
Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity
J Med Chem (2009) 52, 852-857. PubMed Europe PubMed DOI PMC EPMC S I -
Verissimo,E., Berry,N., Gibbons,P., Cristiano,M.L., Rosenthal,P.J., Gut,J., Ward,S.A. and O'Neill,P.M.
Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors
Bioorg Med Chem Lett (2008) 18, 4210-4214. PubMed Europe PubMed DOI I -
Schulz,F., Gelhaus,C., Degel,B., Vicik,R., Heppner,S., Breuning,A., Leippe,M., Gut,J., Rosenthal,P.J. and Schirmeister,T.
Screening of protease inhibitors as antiplasmodial agents. Part I: aziridines and epoxides
ChemMedChem (2007) 2, 1214-1224. PubMed Europe PubMed DOI I -
Desai,P.V., Patny,A., Sabnis,Y., Tekwani,B., Gut,J., Rosenthal,P., Srivastava,A. and Avery,M.
Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database
J Med Chem (2004) 47, 6609-6615. PubMed Europe PubMed DOI I -
[YEAR:15-9-2004]Na,B.K., Kim,T.S., Rosenthal,P.J., Lee,J.K. and Kong,Y.
Evaluation of cysteine proteases of Plasmodium vivax as antimalarial drug targets: sequence analysis and sensitivity to cysteine protease inhibitors
Parasitol Res (15-9-2004) 94, 312-317. PubMed Europe PubMed DOI I -
Lee,B.J., Singh,A., Chiang,P., Kemp,S.J., Goldman,E.A., Weinhouse,M.I., Vlasuk,G.P. and Rosenthal,P.J.
Antimalarial activities of novel synthetic cysteine protease inhibitors
Antimicrobial Agents Chemother (2003) 47, 3810-3814. PubMed Europe PubMed DOI PMC EPMC I -
Shenai,B.R., Lee,B.J., Alvarez-Hernandez,A., Chong,P.Y., Emal,C.D., Neitz,R.J., Roush,W.R. and Rosenthal,P.J.
Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones
Antimicrobial Agents Chemother (2003) 47, 154-160. PubMed Europe PubMed DOI PMC EPMC I
2024
2019
2018
2016
2014
2013
2012
2011
2010
2009
2008
2007
2004
2003
